Riddell Centre Emerging Cancer Scholar Award for Cancer Immunotherapy

Objective:

The Riddell Centre Emerging Cancer Scholar Award for Cancer Immunotherapy aims to support and develop the next generation of leaders in cancer immunotherapy research. This award focuses on recruiting and / or retaining outstanding PhD and MSc students.

The Riddell Centre’s research is strategically focused on advancing the following goals:

• Developing novel cell and immune-based therapies for hard-to-treat cancers
• Enhancing the effectiveness and safety of cancer immunotherapies
• Advancing new treatment approaches through clinical trials
• Training scientists and clinicians to excel in the cancer immunotherapy field

Eligibility Requirements:

Applications are open to:

• Prospective or current full-time PhD/MSc students at the University of Calgary, supervised by a current or prospective Riddell Centre faculty member.
• Applicants must be accepted into a full-time MSc or PhD program at the University of Calgary under the supervision of a full member of the Riddell Centre for Cancer Immunotherapy.

Additional Requirements:

• Award recipients and their supervisors must become members of the Riddell Centre and the Arnie Charbonneau Cancer Institute, adhering to all membership guidelines.
• Applicants must not have previously received funding through a Riddell Centre Graduate Scholarship.

Number of Awards: Up to 4 awards per year, subject to available funding

Duration: Scholarships are awarded for a period of 2 years

Full award details and application instructions can be found in the Award Guide.